← Leaderboards
Alan D. Rogol
University Of Virginia Charlottesville
$2,440,436
Attributed
$2,440,436
Total exposure
17
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$2,440,436 · 17
By mechanism
M01$2,440,436 · 17
Top collaborators
No co-investigators on record.
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Michael O Thorner$7,721,062
- Mary L Vance$1,068,571
- Lisa M Pastore$2,988,625
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchHuman Therapy EvaluationSomatotropinChild (0-11)Body CompositionHuman PubertyChild Physical DevelopmentAdolescence (12-20)Hormone TherapyHormone Regulation /Control MechanismEndocrine DisorderMiddle Childhood (6-11)Human DataPostnatal Growth DisorderSex HormonesObesityNutrition Related TagLeptinDrug Screening /EvaluationEndocrine Disorder ChemotherapyClinical Trial Phase IPediatric Neoplasm /CancerDevelopmental Nutrition
Grant awards (62)
BODY COMPOSITION, GROWTH, PUBERTY IN SURVIVORS OF CHILDHOOD ALL &NHL$48,533
M01 · FY2002 · RR
PHASE III STUDY OF NUTROPIN THERAPY IN PUBERTAL CHILDREN WITH GH DEFICIENCY$48,533
M01 · FY2002 · RR
PROLEASE HGH MONTHLY IN CHILDREN W GROWTH FAILURE DUE TO GROWTH HORMONE DEFICIENC$48,533
M01 · FY2002 · RR
SAFETY AND EFFICACY OF PROLEASE HGH$48,533
M01 · FY2002 · RR
FEEDBACK MECHANISMS IN SEX HORMONE INDUCED GH RELEASE IN PREPUBERAL /PUBERTAL CHI$48,533
M01 · FY2002 · RR
ALTERATIONS IN BODY COMPOSITION AND GROWTH AT PUBERTY$48,533
M01 · FY2002 · RR
METFORMIN EFFECTS ON LEPTIN LEVELS AND BODY COMPOSITION IN OBESE CHILDREN$48,533
M01 · FY2002 · RR
GROWTH, ADOLESCENT DEVELOPMENT AND BODY COMPOSITION IN SURVIVORS OF CNS TUMORS$48,533
M01 · FY2002 · RR
D CHIRO INOSITOL IN PREPUBERTAL OR LATE ADOLESCENT CHILDREN$48,533
M01 · FY2002 · RR
INITIATION OF HORMONAL THERAPIES IN CHILDREN$48,533
M01 · FY2002 · RR
EFFECTS OF PUBERTAL TIMING ON BODY COMPOSITION AND GROWTH$48,533
M01 · FY2002 · RR
ALTERATIONS IN BODY COMPOSITION IN CHILDREN WITH ADHD$48,533
M01 · FY2002 · RR
METHOTREXATE FOR SEVERE MALABSORPTION IN AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE I$48,533
M01 · FY2002 · RR
EXERCISE TRAINING, BODY COMPOSITION, GH, AND LEPTIN IN OVERWEIGHT CHILDREN$48,533
M01 · FY2002 · RR
METHOTREXATE FOR SEVERE MALABSORPTION IN AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE I$48,533
M01 · FY2001 · RR
METFORMIN EFFECTS ON LEPTIN LEVELS AND BODY COMPOSITION IN OBESE CHILDREN$48,533
M01 · FY2001 · RR
D CHIRO INOSITOL IN PREPUBERTAL OR LATE ADOLESCENT CHILDREN$48,533
M01 · FY2001 · RR
PHASE III STUDY OF NUTROPIN THERAPY IN PUBERTAL CHILDREN WITH GH DEFICIENCY$48,533
M01 · FY2001 · RR
ALTERATIONS IN BODY COMPOSITION AND GROWTH AT PUBERTY$48,533
M01 · FY2001 · RR
EFFECTS OF PUBERTAL TIMING ON BODY COMPOSITION AND GROWTH$48,533
M01 · FY2001 · RR
INITIATION OF HORMONAL THERAPIES IN CHILDREN$48,533
M01 · FY2001 · RR
GROWTH, ADOLESCENT DEVELOPMENT AND BODY COMPOSITION IN SURVIVORS OF CNS TUMORS$48,533
M01 · FY2001 · RR
SAFETY AND EFFICACY OF PROLEASE HGH$48,533
M01 · FY2001 · RR
PROLEASE HGH MONTHLY IN CHILDREN W GROWTH FAILURE DUE TO GROWTH HORMONE DEFICIENC$48,533
M01 · FY2001 · RR
BODY COMPOSITION, GROWTH, PUBERTY IN SURVIVORS OF CHILDHOOD ALL &NHL$48,533
M01 · FY2001 · RR
EXERCISE TRAINING, BODY COMPOSITION, GH, AND LEPTIN IN OVERWEIGHT CHILDREN$48,533
M01 · FY2001 · RR
ALTERATIONS IN BODY COMPOSITION IN CHILDREN WITH ADHD$48,533
M01 · FY2001 · RR
FEEDBACK MECHANISMS IN SEX HORMONE INDUCED GH RELEASE IN PREPUBERAL /PUBERTAL CHI$48,533
M01 · FY2001 · RR
MK 677 IN GH DEFICIENT CHILDREN$248,088
M01 · FY2000 · RR
BONE MINERALIZATION AND ITS RELATION TO PUBERTAL DEVELOPMENT IN CHILDREN WITH CF$248,088
M01 · FY2000 · RR
CORRELATIONS OF IMMUNOFUNCTIONAL GH ASSAY W/ STAND IMMUNOASSAY IN NORMALS$248,088
M01 · FY2000 · RR
MK 677 IN GH DEFICIENT CHILDREN$28,104
M01 · FY2000 · RR
PHASE III STUDY OF NUTROPIN THERAPY IN PUBERTAL CHILDREN WITH GH DEFICIENCY$28,104
M01 · FY2000 · RR
ALTERATIONS IN BODY COMPOSITION AND GROWTH AT PUBERTY$28,104
M01 · FY2000 · RR
EFFECTS OF PUBERTAL TIMING ON BODY COMPOSITION AND GROWTH$28,104
M01 · FY2000 · RR
INITIATION OF HORMONAL THERAPIES IN CHILDREN$28,104
M01 · FY2000 · RR
GROWTH, ADOLESCENT DEVELOPMENT AND BODY COMPOSITION IN SURVIVORS OF CNS TUMORS$28,104
M01 · FY2000 · RR
SAFETY AND EFFICACY OF PROLEASE HGH$28,104
M01 · FY2000 · RR
CORRELATIONS OF IMMUNOFUNCTIONAL GH ASSAY W/ STAND IMMUNOASSAY IN NORMALS$28,104
M01 · FY2000 · RR
BODY COMPOSITION, GROWTH, PUBERTY IN SURVIVORS OF CHILDHOOD ALL &NHL$28,104
M01 · FY2000 · RR
EXERCISE TRAINING, BODY COMPOSITION, GH, AND LEPTIN IN OVERWEIGHT CHILDREN$28,104
M01 · FY2000 · RR
D CHIRO INOSITOL IN PREPUBERTAL OR LATE ADOLESCENT CHILDREN$28,104
M01 · FY2000 · RR
METFORMIN EFFECTS ON LEPTIN LEVELS AND BODY COMPOSITION IN OBESE CHILDREN$28,104
M01 · FY2000 · RR
ALTERATIONS IN BODY COMPOSITION IN CHILDREN WITH ADHD$0
M01 · FY2000 · RR
ALTERATIONS IN BODY COMPOSITION IN CHILDREN WITH ADHD$0
M01 · FY2000 · RR
FEEDBACK MECHANISMS IN SEX HORMONE INDUCED GH RELEASE IN PREPUBERAL /PUBERTAL CHI$0
M01 · FY2000 · RR
FEEDBACK MECHANISMS IN SEX HORMONE INDUCED GH RELEASE IN PREPUBERAL /PUBERTAL CHI$0
M01 · FY2000 · RR
METHOTREXATE FOR SEVERE MALABSORPTION IN AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE I$0
M01 · FY2000 · RR
METHOTREXATE FOR SEVERE MALABSORPTION IN AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE I$0
M01 · FY2000 · RR
METFORMIN EFFECTS ON LEPTIN LEVELS AND BODY COMPOSITION IN OBESE CHILDREN$0
M01 · FY2000 · RR
D CHIRO INOSITOL IN PREPUBERTAL OR LATE ADOLESCENT CHILDREN$0
M01 · FY2000 · RR
EXERCISE TRAINING, BODY COMPOSITION, GH, AND LEPTIN IN OVERWEIGHT CHILDREN$0
M01 · FY2000 · RR
BODY COMPOSITION, GROWTH, PUBERTY IN SURVIVORS OF CHILDHOOD ALL &NHL$0
M01 · FY2000 · RR
PROLEASE HGH MONTHLY IN CHILDREN W GROWTH FAILURE DUE TO GROWTH HORMONE DEFICIENC$0
M01 · FY2000 · RR
PROLEASE HGH MONTHLY IN CHILDREN W GROWTH FAILURE DUE TO GROWTH HORMONE DEFICIENC$0
M01 · FY2000 · RR
PHASE III STUDY OF NUTROPIN THERAPY IN PUBERTAL CHILDREN WITH GH DEFICIENCY$0
M01 · FY2000 · RR
SAFETY AND EFFICACY OF PROLEASE HGH$0
M01 · FY2000 · RR
GROWTH, ADOLESCENT DEVELOPMENT AND BODY COMPOSITION IN SURVIVORS OF CNS TUMORS$0
M01 · FY2000 · RR
BONE MINERALIZATION AND PUBERTAL DEVELOPMENT IN CFC$0
M01 · FY2000 · RR
INITIATION OF HORMONAL THERAPIES IN CHILDREN$0
M01 · FY2000 · RR
EFFECTS OF PUBERTAL TIMING ON BODY COMPOSITION AND GROWTH$0
M01 · FY2000 · RR
ALTERATIONS IN BODY COMPOSITION AND GROWTH AT PUBERTY$0
M01 · FY2000 · RR